131 related articles for article (PubMed ID: 37877328)
1. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
Miyakuni S; Maeda D; Matsue Y; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Matsumura A; Minamino T
J Am Heart Assoc; 2022 Dec; 11(24):e025803. PubMed ID: 36515231
[TBL] [Abstract][Full Text] [Related]
4. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
[TBL] [Abstract][Full Text] [Related]
7. Role of serial
Okafor J; Khattar R; Kouranos V; Ohri S; Diana D; Ebeke E; Azzu A; Ahmed R; Wells A; Baksi AJ; Sharma R; Wechalekar K
J Nucl Cardiol; 2024 May; 35():101842. PubMed ID: 38479574
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
[TBL] [Abstract][Full Text] [Related]
9. Pre-Treatment Myocardial
Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
Patel VN; Pieper JA; Poitrasson-Rivière A; Kopin D; Cascino T; Aaronson K; Murthy VL; Koelling T
J Nucl Cardiol; 2022 Oct; 29(5):2460-2470. PubMed ID: 34505261
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
12. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts.
Nordenswan HK; Lehtonen J; Ekström K; Räisänen-Sokolowski A; Mäyränpää MI; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
J Am Heart Assoc; 2021 Mar; 10(6):e019415. PubMed ID: 33660520
[TBL] [Abstract][Full Text] [Related]
13. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
[TBL] [Abstract][Full Text] [Related]
14. Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis.
Hutt E; Brizneda MV; Goldar G; Aguilera J; Wang TKM; Taimeh Z; Culver D; Callahan T; Tang WHW; Cremer PC; Jaber WA; Ribeiro Neto ML; Jellis CL
Europace; 2023 Aug; 25(9):. PubMed ID: 37721485
[TBL] [Abstract][Full Text] [Related]
15. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
16. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
Nabeta T; Kitai T; Naruse Y; Taniguchi T; Yoshioka K; Tanaka H; Okumura T; Sato S; Baba Y; Kida K; Tamaki Y; Matsumoto S; Matsue Y
Eur Heart J; 2022 Sep; 43(36):3450-3459. PubMed ID: 35781334
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
Elwazir M; Krause ML; Bois JP; Christopoulos G; Kendi AT; Cooper JLT; Jouni H; Abouezzeddine OF; Chareonthaitawee P; Abdelshafee M; Amin S
J Card Fail; 2022 Feb; 28(2):247-258. PubMed ID: 34320381
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]